Abstract
Background: Overweight/obesity causes low-grade systemic in ammation and up-regulates the iron regulator hepcidin and reduces fractional iron absorption (FIA) even when iron stores are low. Pregnancy increases the dietary iron requirement to support expansion of maternal blood volume and fetal needs. It is unclear whether and/or to what extent overweight/obese pregnancy in uences FIA, iron transfer to the fetus and risk of iron de ciency in the mother and newborn. Iron de ciency early in life has multiple negative e ects on child development. With obesity in- creasing in prevalence in most countries, if obesity before and during pregnancy has detrimental e ects on infant iron status this may impair child development, and have important public health consequences.
In this study, we (1) determined the impact of maternal overweight/obesity on: a) FIA in preg- nancy; b) transfer of iron to the fetus and c) newborn iron status; (2) investigated the relationship between BMI, hepcidin, plasma ferritin (PF) and in ammatory markers; and (3) compared di er- ences in maternal iron needs during the 2nd and 3rd trimester; and (4) estimated the infant’s iron requirement during the rst two years of life.
Methods: In this ongoing multicenter (Switzerland, ailand, Mexico) prospective case-control study (normal-weight n=36; overweight/obese n=36) we administered labeled [57Fe]- or [58Fe]- FeSO4 to women during the 2nd and 3rd trimester of pregnancy. We measured FIA determining erythrocyte incorporation of iron stable isotopes 14 days a er administration, and monitored, from pregnancy week (PW) 12 to PW 36, iron-, in ammation and hepcidin. Iron transfer to the fetus was determined as iron stable isotope concentration in cord blood. Iron status and iron stable isotope concentrations were then monitored in children at 3, 6, 12, 18 and 24 months.
Results: Subject characteristics (mean±SD) in PW 12 for the normal-weight/obese were: age: 32±6/33±5 years, BMI: 20.8±2.5/41.0±7.4 kg/m2, hemoglobin: 12.1±0.9/13.5±0.8 g/dL and PF: 61±23/47±24 μg/L. Preliminary data indicate 83% and 24% lower FIA in the 2nd trimester compared to the 3rd
in normal-weight and overweight/obese pregnant women, respectively. Iron isotopes were read-
ily detectable in cord blood. e [58Fe]/[57Fe]-ratio measured in cord blood correlated positively with the [58Fe]/[57Fe]-ratio determined in the mother in the 3rd trimester.
Conclusions: In normal pregnancy, FIA increases over time to support increased iron needs of mother and fetus. is is consistent with decreasing hepcidin concentrations during pregnancy. Our preliminary data indicate there is a sharply reduced increase in FIA in overweight/obese preg- nant women compared to normal weight women, suggesting increased hepcidin may continue to play an important regulatory role in the former group even in the 3rd trimester. us, although iron demands are strongly increased, overweight/obesity may impair adequate iron supply to the expecting mother and the fetus due to persistent subclinical in ammation.
In this study, we (1) determined the impact of maternal overweight/obesity on: a) FIA in preg- nancy; b) transfer of iron to the fetus and c) newborn iron status; (2) investigated the relationship between BMI, hepcidin, plasma ferritin (PF) and in ammatory markers; and (3) compared di er- ences in maternal iron needs during the 2nd and 3rd trimester; and (4) estimated the infant’s iron requirement during the rst two years of life.
Methods: In this ongoing multicenter (Switzerland, ailand, Mexico) prospective case-control study (normal-weight n=36; overweight/obese n=36) we administered labeled [57Fe]- or [58Fe]- FeSO4 to women during the 2nd and 3rd trimester of pregnancy. We measured FIA determining erythrocyte incorporation of iron stable isotopes 14 days a er administration, and monitored, from pregnancy week (PW) 12 to PW 36, iron-, in ammation and hepcidin. Iron transfer to the fetus was determined as iron stable isotope concentration in cord blood. Iron status and iron stable isotope concentrations were then monitored in children at 3, 6, 12, 18 and 24 months.
Results: Subject characteristics (mean±SD) in PW 12 for the normal-weight/obese were: age: 32±6/33±5 years, BMI: 20.8±2.5/41.0±7.4 kg/m2, hemoglobin: 12.1±0.9/13.5±0.8 g/dL and PF: 61±23/47±24 μg/L. Preliminary data indicate 83% and 24% lower FIA in the 2nd trimester compared to the 3rd
in normal-weight and overweight/obese pregnant women, respectively. Iron isotopes were read-
ily detectable in cord blood. e [58Fe]/[57Fe]-ratio measured in cord blood correlated positively with the [58Fe]/[57Fe]-ratio determined in the mother in the 3rd trimester.
Conclusions: In normal pregnancy, FIA increases over time to support increased iron needs of mother and fetus. is is consistent with decreasing hepcidin concentrations during pregnancy. Our preliminary data indicate there is a sharply reduced increase in FIA in overweight/obese preg- nant women compared to normal weight women, suggesting increased hepcidin may continue to play an important regulatory role in the former group even in the 3rd trimester. us, although iron demands are strongly increased, overweight/obesity may impair adequate iron supply to the expecting mother and the fetus due to persistent subclinical in ammation.
| Original language | English |
|---|---|
| Pages | 146 |
| Number of pages | 147 |
| Publication status | Published - 10 Dec 2018 |
| Event | INTERNATIONAL SYMPOSIUM ON Understanding the Double Burden of Malnutrition for Effective Interventions. - International Atomic Energy Agency, Viena, Austria Duration: 10 Dec 2018 → 14 Dec 2018 https://www.who.int/nutrition/events/2018-iaea-symposium-doubleburdenmalnutrition-programme.pdf |
Conference
| Conference | INTERNATIONAL SYMPOSIUM ON Understanding the Double Burden of Malnutrition for Effective Interventions. |
|---|---|
| Country/Territory | Austria |
| City | Viena |
| Period | 10/12/18 → 14/12/18 |
| Internet address |
